{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:57:45Z","timestamp":1773669465805,"version":"3.50.1"},"reference-count":28,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":9407,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1992,4]]},"abstract":"<jats:p>The effects of moclobemide (300\u2013600 mg\/day), a reversible monoamine oxidase inhibitor \u2013 A (MAOI-A), were compared in a double-blind, multi-centre trial with those of clomipramine (100\u2013200 mg\/day) on 129 in-patients suffering from endogenous depression (according to ICD\u20139 and the Newcastle Scale). No significant differences in efficacy were seen between the two treatment groups. In the moclobemide group the mean scores on the MADRS were 36.4 on day 0 and 13.2 on day 42 (end-point analysis); scores were 37.4 and 10.9 respectively in the clomipramine group. An earlier onset of antidepressant activity was noted for moclobemide. Tolerability was significantly better for moclobemide, as shown by the Clinical Global Impression of Tolerance (CGI<jats:sub>T<\/jats:sub>). Anticholinergic effects, weight gain and orthostatic hypotension were more frequent in the clomipramine group. No biological treatment-related changes were observed.<\/jats:p>","DOI":"10.1192\/bjp.160.4.519","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T04:56:07Z","timestamp":1224046567000},"page":"519-524","source":"Crossref","is-referenced-by-count":48,"title":["Moclobemide Versus Clomipramine in Endogenous Depression"],"prefix":"10.1192","volume":"160","author":[{"given":"J. D.","family":"Guelfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Payan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fermanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Pedarriosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000036631_ref4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1192\/S0007125000297535","article-title":"Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM\u2013III): An Austrian double-blind, multi-centre study","volume":"155","author":"Baumhackl","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"S0007125000036631_ref2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.3.256"},{"key":"S0007125000036631_ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1192\/S0007125000297523","article-title":"A double-blind comparative trial of moclobemide versus imipramine and placebo in major depressive episodes","volume":"155","author":"Versiani","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"S0007125000036631_ref25","volume-title":"Monoamine Oxidase and Disease, Prospects for Therapy with Reversible Inhibitors","author":"Stefanis","year":"1984"},{"key":"S0007125000036631_ref21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0767399X00001577","article-title":"The Symptom Check-List 90R (SCL-90R) in a French general psychiatric 708 outpatient sample: is there a factor structure","volume":"4","author":"Pariente","year":"1989","journal-title":"Psychiatry and Psychobiology"},{"key":"S0007125000036631_ref12","volume-title":"SCL 90\u2013R: Administration, Scoring and Procedure. Manual I","author":"Derogatis","year":"1977"},{"key":"S0007125000036631_ref24","doi-asserted-by":"publisher","DOI":"10.1111\/acps.1983.68.s310.42"},{"key":"S0007125000036631_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800030064006"},{"key":"S0007125000036631_ref28","volume-title":"Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases (ICD-9)","year":"1978"},{"key":"S0007125000036631_ref10","first-page":"210","volume-title":"Guidelines of the Quality, Safety and Efficacy of Medicinal Products for Human Use","year":"1989"},{"key":"S0007125000036631_ref11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3565(25)23665-5","article-title":"Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A","volume":"248","author":"Da Prada","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"S0007125000036631_ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"S0007125000036631_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(85)90069-2"},{"key":"S0007125000036631_ref7","first-page":"881","article-title":"Clinical trial of the treatment of depressive illness","volume":"i","year":"1965","journal-title":"British Medical Journal"},{"key":"S0007125000036631_ref1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S0007125000036631_ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017421"},{"key":"S0007125000036631_ref22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1192\/S0007125000297432","article-title":"A European study of views on the use of monoamine oxidase inhibitors","volume":"155","author":"Paykel","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"S0007125000036631_ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.113.497.349"},{"key":"S0007125000036631_ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.149"},{"key":"S0007125000036631_ref13","volume-title":"BMDP Statistical Software","author":"Dixon","year":"1985"},{"key":"S0007125000036631_ref14","first-page":"257","article-title":"La CHESS, utilisation dans la pathologic anxieuse et depressive. Structure factorielle","volume":"141","author":"Guelfi","year":"1983","journal-title":"Annates M\u00e9dico-psychologiques"},{"key":"S0007125000036631_ref17","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197714030-00001"},{"key":"S0007125000036631_ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"S0007125000036631_ref19","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"S0007125000036631_ref27","volume-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"key":"S0007125000036631_ref23","volume-title":"Moclobemide: Drug and Alcohol Interactions","author":"Puech","year":"1990"},{"key":"S0007125000036631_ref8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0022-3565(25)23664-3","article-title":"Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A","volume":"248","author":"Burkard","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"S0007125000036631_ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb01206.x"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000036631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:21:10Z","timestamp":1738437670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000036631\/type\/journal_article"}},"subtitle":["A Double-Blind Randomised Clinical Trial"],"short-title":[],"issued":{"date-parts":[[1992,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,4]]}},"alternative-id":["S0007125000036631"],"URL":"https:\/\/doi.org\/10.1192\/bjp.160.4.519","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,4]]}}}